We show here that the expression of miR-377 is completely silenced in melanoma cell lines and samples, and that it directly targets both the transcription factor E2F3 and MAP3K7, a tyrosine kinase along the MAPK pathway, known to be important in the activation of the NF-kB signaling pathway. The gene discussed is NFKB1; the disease is melanoma.